Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
EMVODODSTAT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
EMVODODSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
053QD2I96A
Molecule Type:
Small molecule
Molecular Formula:
C25H20Cl2N2O3
Molecular Weight:
467.35
AlogP:
6.63
PSA:
54.56
HBD:
1.0
HBA:
#RotB:
3.0
Source:
CYTIDINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
CYTIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
5CSZ8459RP
Molecule Type:
Small molecule
Molecular Formula:
C9H13N3O5
Molecular Weight:
243.22
AlogP:
-2.56
PSA:
130.83
HBD:
4.0
HBA:
#RotB:
2.0
Source:
BUCINDOLOL HYDROCHLORIDE
(2)
Small molecule
Adrenergic receptor alpha-1 antagonist
Unknown
Investigational
Unknown
BUCINDOLOL HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
SH683G4QII
Molecule Type:
Small molecule
Molecular Formula:
C22H26ClN3O2
Molecular Weight:
399.92
AlogP:
3.39
PSA:
81.07
HBD:
3.0
HBA:
#RotB:
8.0
Source:
BERUBICIN HYDROCHLORIDE
(2)
Small molecule
DNA topoisomerase II inhibitor
Unknown
Investigational
Unknown
BERUBICIN HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
7BA3X03948
Molecule Type:
Small molecule
Molecular Formula:
C34H36ClNO11
Molecular Weight:
670.11
AlogP:
2.23
PSA:
195.07
HBD:
5.0
HBA:
#RotB:
8.0
Source:
CADISEGLIATIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
CADISEGLIATIN
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RADEZOLID
(2)
Small molecule
Bacterial 70S ribosome inhibitor
Unknown
Investigational
Unknown
RADEZOLID
×
Maximum Phase:
2
First Approval:
None
UNII:
53PC6LO35W
Molecule Type:
Small molecule
Molecular Formula:
C22H23FN6O3
Molecular Weight:
438.46
AlogP:
2.36
PSA:
112.24
HBD:
3.0
HBA:
#RotB:
8.0
Source:
GPI-1485
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
GPI-1485
×
Maximum Phase:
2
First Approval:
None
UNII:
0709BVY57W
Molecule Type:
Small molecule
Molecular Formula:
C12H19NO4
Molecular Weight:
241.29
AlogP:
1.07
PSA:
74.68
HBD:
1.0
HBA:
#RotB:
4.0
Source:
IBOGAINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
IBOGAINE
×
Maximum Phase:
2
First Approval:
None
UNII:
3S814I130U
Molecule Type:
Small molecule
Molecular Formula:
C20H26N2O
Molecular Weight:
310.44
AlogP:
3.94
PSA:
28.26
HBD:
1.0
HBA:
#RotB:
2.0
Source:
TETRAHYDROURIDINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TETRAHYDROURIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
0NIZ8H6OL8
Molecule Type:
Small molecule
Molecular Formula:
C9H16N2O6
Molecular Weight:
248.24
AlogP:
-2.84
PSA:
122.49
HBD:
5.0
HBA:
#RotB:
2.0
Source:
AZD4205
(2)
Small molecule
Tyrosine-protein kinase JAK1 inhibitor
Unknown
Investigational
Unknown
AZD4205
×
Maximum Phase:
2
First Approval:
None
UNII:
3BY9Z3M34G
Molecule Type:
Small molecule
Molecular Formula:
C25H31N9O2
Molecular Weight:
489.58
AlogP:
2.69
PSA:
116.23
HBD:
3.0
HBA:
#RotB:
7.0
Source:
ODELEPRAN
(2)
Small molecule
Opioid receptors; mu/kappa/delta antagonist
Unknown
Investigational
Unknown
ODELEPRAN
×
Maximum Phase:
2
First Approval:
None
UNII:
4VZT670SD9
Molecule Type:
Small molecule
Molecular Formula:
C20H24FN3O3
Molecular Weight:
373.43
AlogP:
3.02
PSA:
86.47
HBD:
2.0
HBA:
#RotB:
8.0
Source:
SIREMADLIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
SIREMADLIN
×
Maximum Phase:
2
First Approval:
None
UNII:
0282IF4JC8
Molecule Type:
Small molecule
Molecular Formula:
C26H24Cl2N6O4
Molecular Weight:
555.42
AlogP:
4.69
PSA:
104.37
HBD:
0.0
HBA:
#RotB:
6.0
Source:
NARONAPRIDE
(2)
Small molecule
Serotonin 4 (5-HT4) receptor agonist
Unknown
Investigational
Unknown
NARONAPRIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
058896B00B
Molecule Type:
Small molecule
Molecular Formula:
C27H41ClN4O5
Molecular Weight:
537.1
AlogP:
2.95
PSA:
106.36
HBD:
2.0
HBA:
#RotB:
11.0
Source:
PF-04531083
(2)
Small molecule
Sodium channel protein type X alpha subunit blocker
Unknown
Investigational
Unknown
PF-04531083
×
Maximum Phase:
2
First Approval:
None
UNII:
40497CY7Y3
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELOCALCITOL
(2)
Small molecule
Vitamin D receptor agonist
Unknown
Investigational
Unknown
ELOCALCITOL
×
Maximum Phase:
2
First Approval:
None
UNII:
2WDS5F2V6Q
Molecule Type:
Small molecule
Molecular Formula:
C29H44O3
Molecular Weight:
440.67
AlogP:
6.18
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
7.0
Source:
FIRATEGRAST
(2)
Small molecule
Integrin alpha-4/beta-1 antagonist
Unknown
Investigational
Unknown
FIRATEGRAST
×
Maximum Phase:
2
First Approval:
None
UNII:
OJY3SK9H5F
Molecule Type:
Small molecule
Molecular Formula:
C27H27F2NO6
Molecular Weight:
499.51
AlogP:
4.61
PSA:
94.09
HBD:
2.0
HBA:
#RotB:
11.0
Source:
SODIUM BUTYRATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
SODIUM BUTYRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
8RAS91C36W
Molecule Type:
Small molecule
Molecular Formula:
C4H7NaO2
Molecular Weight:
110.09
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
AZD7009
(2)
Small molecule
HERG blocker
Unknown
Investigational
Unknown
AZD7009
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C23H34N4O5
Molecular Weight:
446.55
AlogP:
1.21
PSA:
107.29
HBD:
2.0
HBA:
#RotB:
8.0
Source:
AFP-464 FREE SALT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
AFP-464 FREE SALT
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C24H27F3N4O3
Molecular Weight:
476.5
AlogP:
3.94
PSA:
137.37
HBD:
4.0
HBA:
#RotB:
9.0
Source:
FADOLMIDINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
FADOLMIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
WLN5FGH1CY
Molecule Type:
Small molecule
Molecular Formula:
C13H14N2O
Molecular Weight:
214.27
AlogP:
2.39
PSA:
48.91
HBD:
2.0
HBA:
#RotB:
2.0
Source:
RSV-604
(2)
Small molecule
Nucleoprotein inhibitor
Unknown
Investigational
Unknown
RSV-604
×
Maximum Phase:
2
First Approval:
None
UNII:
6NF9HI6D98
Molecule Type:
Small molecule
Molecular Formula:
C22H17FN4O2
Molecular Weight:
388.4
AlogP:
3.76
PSA:
82.59
HBD:
3.0
HBA:
#RotB:
3.0
Source:
NRX195183
(2)
Small molecule
Retinoic acid receptor alpha agonist
Unknown
Investigational
Unknown
NRX195183
×
Maximum Phase:
2
First Approval:
None
UNII:
RC87L028HU
Molecule Type:
Small molecule
Molecular Formula:
C22H22ClF2NO4
Molecular Weight:
437.87
AlogP:
5.62
PSA:
86.63
HBD:
3.0
HBA:
#RotB:
3.0
Source:
TEMUTERKIB
(2)
Small molecule
Mitogen-activated protein kinase; ERK1/ERK2 inhibitor
Unknown
Investigational
Unknown
TEMUTERKIB
×
Maximum Phase:
2
First Approval:
None
UNII:
V0Q46LFE6F
Molecule Type:
Small molecule
Molecular Formula:
C22H27N7O2S
Molecular Weight:
453.57
AlogP:
2.71
PSA:
88.41
HBD:
1.0
HBA:
#RotB:
6.0
Source:
BLEOMYCIN A6
(2)
Small molecule
DNA disrupting agent
Unknown
Investigational
Unknown
BLEOMYCIN A6
×
Maximum Phase:
2
First Approval:
None
UNII:
0B19OCB220
Molecule Type:
Small molecule
Molecular Formula:
C60H96N20O21S2
Molecular Weight:
1497.68
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
VISTUSERTIB
(2)
Small molecule
Serine/threonine-protein kinase mTOR inhibitor
Unknown
Investigational
Unknown
VISTUSERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
0BSC3P4H5X
Molecule Type:
Small molecule
Molecular Formula:
C25H30N6O3
Molecular Weight:
462.55
AlogP:
2.5
PSA:
92.71
HBD:
1.0
HBA:
#RotB:
4.0
Source:
LIAROZOLE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
LIAROZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
K0Q29TGV9Y
Molecule Type:
Small molecule
Molecular Formula:
C17H13ClN4
Molecular Weight:
308.77
AlogP:
4.05
PSA:
46.5
HBD:
1.0
HBA:
#RotB:
3.0
Source:
EMPRUMAPIMOD
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
EMPRUMAPIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-05089771
(2)
Small molecule
Sodium channel protein type IX alpha subunit blocker
Unknown
Investigational
Unknown
PF-05089771
×
Maximum Phase:
2
First Approval:
None
UNII:
25U4N985O2
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OGLEMILAST
(2)
Small molecule
Phosphodiesterase 4 inhibitor
Unknown
Investigational
Unknown
OGLEMILAST
×
Maximum Phase:
2
First Approval:
None
UNII:
67GXQ6WCC6
Molecule Type:
Small molecule
Molecular Formula:
C20H13Cl2F2N3O5S
Molecular Weight:
516.31
AlogP:
5.51
PSA:
110.53
HBD:
2.0
HBA:
#RotB:
6.0
Source:
UCB-1184197
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
UCB-1184197
×
Maximum Phase:
2
First Approval:
None
UNII:
9A54BAZ0YA
Molecule Type:
Small molecule
Molecular Formula:
C28H29BrN4O3
Molecular Weight:
549.47
AlogP:
5.58
PSA:
93.21
HBD:
2.0
HBA:
#RotB:
8.0
Source:
ARZOXIFENE HYDROCHLORIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ARZOXIFENE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
FU88PI0433
Molecule Type:
Small molecule
Molecular Formula:
C28H30ClNO4S
Molecular Weight:
512.07
AlogP:
6.94
PSA:
51.16
HBD:
1.0
HBA:
#RotB:
8.0
Source:
EMODEPSIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
EMODEPSIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
YZ647Y5GC9
Molecule Type:
Small molecule
Molecular Formula:
C60H90N6O14
Molecular Weight:
1119.41
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
EMTRICITABINE, (+/-)-
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
EMTRICITABINE, (+/-)-
×
Maximum Phase:
2
First Approval:
None
UNII:
ULS8902U4O
Molecule Type:
Small molecule
Molecular Formula:
C8H10FN3O3S
Molecular Weight:
247.25
AlogP:
-0.46
PSA:
90.37
HBD:
2.0
HBA:
#RotB:
2.0
Source:
TECALCET
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TECALCET
×
Maximum Phase:
2
First Approval:
None
UNII:
8I16YLE4US
Molecule Type:
Small molecule
Molecular Formula:
C18H22ClNO
Molecular Weight:
303.83
AlogP:
4.63
PSA:
21.26
HBD:
1.0
HBA:
#RotB:
7.0
Source:
NORKETOTIFEN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
NORKETOTIFEN
×
Maximum Phase:
2
First Approval:
None
UNII:
Z24BD2IFB3
Molecule Type:
Small molecule
Molecular Formula:
C18H17NOS
Molecular Weight:
295.41
AlogP:
3.67
PSA:
29.1
HBD:
1.0
HBA:
#RotB:
0.0
Source:
PF-04691502
(2)
Small molecule
PI3-kinase class I inhibitor
Unknown
Investigational
Unknown
PF-04691502
×
Maximum Phase:
2
First Approval:
None
UNII:
4W39NS61KI
Molecule Type:
Small molecule
Molecular Formula:
C22H27N5O4
Molecular Weight:
425.49
AlogP:
2.25
PSA:
125.38
HBD:
2.0
HBA:
#RotB:
6.0
Source:
1
2
…
156
157
158
159
160
161
162
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA